Rocket Pharmaceuticals (RCKT) Tops Q4 EPS by 5c

Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q4 EPS of ($0.38), $0.05 better than the analyst estimate of ($0.43).

For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.

You May Also Be Interested In

• Waymo Explores Split With Uber - FT
• American Fusion receives Texas certification for its fusion engine models
• CalciMedica (CALC) files for 56.02M share offering by selling stockholders